Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Aileron Therapeutics Announces First Patients Treated in Phase 1b Trial of ALRN-6924 in Patients with p53-Mutated Neoadjuvant Breast Cancer

Globe Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Follow us on Google News Follow us on Google News

BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq:ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients’ lives, today announced it has treated the first patients in its Phase 1b randomized, controlled clinical trial evaluating ALRN-6924 to protect against chemotherapy-induced neutropenia and other bone marrow toxicities, as well as toxicities outside of the bone marrow in patients with p53-mutated breast cancer who are being treated with doxorubicin plus cyclophosphamide and docetaxel (AC+D).

Read more at globenewswire.com

Related Symbols

Symbol Last Chg %Chg
ALRN 2.11 +0.18 +9.33%
Aileron Therapeutics Inc

Most Popular News

Super Micro Computer Inc HQ photo-by Tada Images via Shutterstock 1
Super Micro Computer's Quarterly Earnings Preview: What You Need to Know
A close-up shot of Tim Cook_ Image by photovanessacarvalho via Shutterstock_ 2
Apple CEO Tim Cook Just Bought Another 25,000 Shares of Nike Stock. Should You Load Up on NKE Too?
Microsoft logo on building by franz12 via iStock 3
Microsoft Stock Warning: Why Piper Sandler Analysts Just Slashed Their MSFT Price Target by More Than 15%
Microsoft Corporation logo on sign-by Jean-Luc Ichard via iStock 4
Microsoft Stock Could Be 25% Undervalued Based on Its FCF and Analysts' Estimates
Campbell's soup on grocery store shelf by Calle Macarone via Unsplash 5
Campbell’s Isn’t Cheap - It’s Trapped
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.